Fundz Deep Dive
Everything you need to win OptimizeRx — in one platform.
Who to reach, what to say, and why now on OptimizeRx — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on OptimizeRx — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
OptimizeRx Extends Financing Agreement and Announces Share Repurchase Program
Mar 05, 2026•3 months ago
Contract Type
financing_agreement
Description
On March 2, 2026, OptimizeRx Corporation entered into Amendment No. 4 to its Financing Agreement, extending the maturity date by two years to October 11, 2029. The amendment allows the company to repurchase up to $10 million of its common stock before March 15, 2027. Additionally, it extends the period of a 1% applicable premium through October 11, 2027.
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months